What does NAF stand for?

1) Multiple long-term studies show that the identification of atypical epithelial cells found in cytology specimens, such as nipple aspirate fluid (NAF) or fine-needle aspiration (FNA), is also associated with an elevated risk of developing breast cancer, as was observed with open biopsies.

The presentation entitled, "Quantitative Galactose Oxidase Schiff's reaction in Nipple Aspirate Fluid may distinguish women with or without Breast Cancer" concluded by stating that "GOS reactivity as measured by adjusted chroma values are significantly different between normal patients, those with Ductal Carcenoma In Situ and those with invasive cancer" and that "these results warrant further investigation.

Our objective was to determine whether a) testosterone levels in nipple aspirate fluid (NAF), serum, or breast tissue are associated with breast cancer; b) testosterone levels in serum are associated with levels in NAF; c) PSA in NAF, serum, or breast tissue is associated with breast cancer; and d) serum PSA is associated with NAF PSA levels.

The test is performed with a proprietary device for collecting nipple aspirate fluid (NAF).

Lebovic will discuss is an automated, noninvasive method of collecting nipple aspirate fluid from women over age 25, using the HALO[R] Breast Pap Test.

The HALO test is a 5-minute, noninvasive test performed with a proprietary device that delivers a combination of warmth, massage, and vacuum in order to collect nipple aspirate fluid -- which can then be examined to identify women who are at high risk of developing breast cancer.

The HALO system is a five-minute, noninvasive test performed with a proprietary device that delivers a combination of warmth, massage, and suction in order to collect nipple aspirate fluid (NAF) -- which can then be examined to identify women who are at high risk of developing breast cancer in the future.

HALO is FDA-cleared for the collection of nipple aspirate fluid for cytological evaluation.